Literature DB >> 7259217

Topical drug effects on normal and proliferating epidermal cell models.

N J Lowe, R B Stoughton, J L McCullough, G D Weinstein.   

Abstract

The effects of 28 different antiproliferative agents applied topically to normal and hyperproliferative hairless mouse skin were studied. Epidermal cell hyperproliferation was induced by an essential fatty acid-deficient diet or by irradiation with short-wavelength ultraviolet (UV) energy. Epidermal DNA synthesis was measured by hydroxyapatite column chromatography. We compared the effects of these drugs used on normal and hyperproliferative hairless mouse skin with clinical responses in patients with psoriasis treated using the same topical preparations. For most of the drugs tested, the normal and essential fatty acid-deficient mouse model effects showed a good correlation with clinical responses seen in treated patients with psoriasis. The short-wavelength UV energy-treated mouse model effects showed a poorer clinical correlation, perhaps partially caused by wide variations in DNA synthetic rates encountered in the epidermis in this model.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7259217

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  4 in total

1.  The effect of 5-fluorouracil on inhibition of epidermal DNA synthesis in vivo: a comparison of the effect of formulations and a prodrug of 5-FU.

Authors:  K B Sloan; E F Sherertz; R G McTiernan
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

Review 2.  Psoriasis therapy: a current perspective.

Authors:  N J Lowe
Journal:  West J Med       Date:  1983-08

3.  Pharmacological modification of 12-0-tetradecanoylphorbol-13-acetate induced inflammation and epidermal cell proliferation in mouse skin.

Authors:  R J Griffiths; B E Wood; S Li; A Blackham
Journal:  Agents Actions       Date:  1988-12

4.  Effects of chinese formula jueyin granules on psoriasis in an animal model.

Authors:  Tian Ma; Wen-Cheng Jiang; Xin Li; Jie Chen; Tie-Jun Wu; Hua Nian; Rong Xu; Qian-Yuan Huang; Qing-Qing Xiao; Qiang Jian; Fu-Lun Li; Bin Li
Journal:  Evid Based Complement Alternat Med       Date:  2014-08-04       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.